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Abstract
Background: Complex but common maternal diseases such as diabetes and obesity contribute to adverse fetal outcomes.
Understanding of the mechanisms involved is hampered by difficulty in isolating individual elements of complex maternal
states in vivo. We approached this problem in the context of maternal diabetes and sought an approach to expose the
developing fetus in vivo to isolated hyperglycemia in the pregnant rat.
Methodology and Principal Findings: We hypothesized that glucose infused into the arterial supply of one uterine horn
would more highly expose fetuses in the ipsilateral versus contralateral uterine horn. To test this, the glucose tracer
[
18F]fluorodeoxyglucose (FDG) was infused via the left uterine artery. Regional glucose uptake into maternal tissues and
fetuses was quantified using positron emission tomography (PET). Upon infusion, FDG accumulation began in the left-sided
placentae, subsequently spreading to the fetuses. Over two hours after completion of the infusion, FDG accumulation was
significantly greater in left compared to right uterine horn fetuses, favoring the left by 1.960.1 and 2.860.3 fold under
fasted and hyperinsulinemic conditions (p,10
211 n=32-35 and p,10
212 n=27–45) respectively. By contrast, centrally
administered [
3H]-2-deoxyglucose accumulated equally between the fetuses of the two uterine horns. Induction of
significant hyperglycemia (10
3 mg/dL) localized to the left uterine artery was sustained for at least 48 hours while maternal
euglycemia was maintained.
Conclusions and Significance: This approach exposes selected fetuses to localized hyperglycemia in vivo, minimizing
exposure of the mother and thus secondary effects. Additionally, a set of less exposed internal control fetuses are
maintained for comparison, allowing direct study of the in vivo fetal effects of isolated hyperglycemia. Broadly, this
approach can be extended to study a variety of maternal-sided perturbations suspected to directly affect fetal health.
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Introduction
The fetus normally is maintained in a protected environment,
sheltered by maternal and placental homeostasis and detoxifica-
tion mechanisms. When these protections fail or are breached,
significant health consequences to the fetus can occur, inducing
malformations [1], neonatal maladies [2], and/or disease
susceptibilities that may not manifest for decades [3].
In simple cases, fetal consequences are induced by direct action
of a single inciting agent on the fetus or non-maternal extra-fetal
tissues [4]. By contrast, in complex cases, the maternal state
consists of compound perturbations, such that it is often unclear
which specific perturbations of the fetal environment are
responsible for the adverse fetal outcomes [5], [6]. Examples
include diabetes mellitus [7] and obesity [8]. In these complex
phenomena, potential mediators of fetal damage may include
alterations in numerous circulating micro- and macro- nutrients
[9], inflammatory agents [10], and reactive oxygen species [11]. It
often is difficult to induce isolated single maternal perturbations
related to the above complex phenomena and in vivo model
approaches which dissect specific maternal-sided contributors to
fetal pathology are needed.
We have approached this problem in the context of fetal diabetes
exposure, which recapitulates many of the above characteristics.
Diabetes exposure during early fetal development leads to birth
defect risk [7] whereas exposure later in gestation leads to neonatal
maladies [2] as well as risk of insulin resistance and type 2 diabetes
later in life [12], [13]. The Freinkel hypothesis of fuel-mediated
teratogenesis posits that the excess exposure to metabolic fuels
increased by maternal diabetes leads to the adverse fetal and
offspring outcomes [9]. Studies using embryo culture [14], [15] and
epidemiologic correlation [16] have lent credenceto thishypothesis,
as have fuel infusions sufficient to induce systemic maternal
elevations [17] though the latter are complicated by metabolic
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12027spillover [18] such as insulin resistance due to lipid infusion or
hyperlipidemia due to glucose infusion [19]. The overall conclusion
from these studies is that although hyperglycemia is likely the
primary fuel that incites fetal pathology [20] additional fuels
contribute as well, including ketones, fatty acids, triglycerides, and
branched chain amino acids [21]-[23]. However, direct determi-
nation of the effects of individual fuels in vivo on fetal development
and offspring health has been difficult to achieve.
To further address this need, it is hypothesized that glucose
infused into the arterial supply of the uterus would highly expose
fetuses to hyperglycemia while minimizing maternal exposure and
secondary effects. We took advantage of the bicornate nature of
the rat uterus, wherein embryos develop in either the left or the
right horns of the uterus. This is of great experimental utility, since
the two horns of the uterus have distinct blood supplies [24].
Because circulating glucose is rapidly cleared from plasma [25],
the amount of infused glucose reaching the central circulation of
the mother and thus the contralateral fetuses should be
significantly less than the amount reaching the fetuses on the side
of the infusion. Here, we validate this approach, testing for
differential uterine horn hyperglycemic exposure using positron
emission tomography (PET) imaging and glucose metabolic tracers




Blood flow to each uterine horn is primarily provided by its
uterine artery, reaching flow rates of 1-2 mL/min near the end of
gestation [24], [26]. An infusion catheter was advanced from the
left femoral artery such that the tip lay just upstream of the left
uterine artery takeoff (Fig. 1a). Competing blood flow was reduced
by either simply ligating the iliac artery just downstream of the
uterine artery takeoff (surgical approach ‘‘A’’) or by, more
extensively, also tying off two nearby competing arteries (approach
‘‘B’’) (Fig. 1b). Catheter placement was performed on gestational
day #18 and rats were studied by PET scan on gestational day
#20 (Fig. 1c). Maternal weight increased pre-surgery to pre-scan
from 32364 to 33064g (p,0.05, n=11).
Disposition of infused glucose tracer
We hypothesized that glucose infused via the left uterine artery
catheter would have a greater chance of being taken up by the
Figure 1. A model for selective fetal exposure. (a) The vast majority of blood flow to each uterine horn is supplied by each horn’s uterine artery
[24], which derives from the iliac artery. Therefore, infusate from a catheter appropriately placed in the left iliac artery should experience first pass
exposure to fetuses in the left, but not right, uterine horn. The fetuses in the right uterine horn thus serve as internal controls. (b) In surgical approach
‘‘A’’, ligatures (green) were tied around the left internal iliac artery just inferior to the uterine artery take off and around the femoral artery. Surgical
approach ‘‘B’’ included additional ties (blue) around the left superior gluteal and hypogastric trunk arteries. (c) Experimental time-line. (d) Dynamic
PET of the abdomen was initiated upon infusion of FDG, followed by a whole-body scan (WB) at 90-120 minutes, transmission and emission
contamination scans (TE) at 120-160 minutes, and tissue collection after euthanasia at 160 minutes.
doi:10.1371/journal.pone.0012027.g001
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uterine horn. To test this directly, we used the glucose tracer
[
18F]fluorodeoxyglucose (FDG) and positron emission tomography
(PET). An 8.961.1 min bolus infusion of FDG was initiated and
the animals were scanned for the ensuing 120 minutes (Fig. 1d).
Serum
18F concentration peaked at 20 minutes, showing good
correlation between samples collected from the tail or right
femoral artery (Fig. S1a,b). Serum glucose levels remained
euglycemic (13262 mg/dL, n=226) and unchanged throughout
the scan (Fig. S1c,d). The
18F content of tissues, fetuses and
placentae were determined after euthanasia at 16163 in. As
expected, brain and heart showed high degrees of FDG
accumulation, while liver and skeletal muscle experienced less
(Fig. 2a). Like heart and brain, right-sided fetuses and placentae were
exposed to FDG only after it entered the systemic circulation. The
right-sided fetuses showed intermediate avidity for FDG, accumulat-
ing FDG levels nearer that of brain than of muscle, whereas right-
sided placentae showed avidity for FDG that rivaled that of brain.
Importantly, left-sided fetuses and placentae accumulated significant-
ly more FDG than their right-sided counterparts (Fig. 2a). The
uterine horn positions closest to the cervix showed the greatest
differential uptake (Fig. 2b,c), though the left-greater-than-right
pattern was present at nearlyallpositions.On average, each left-sided
fetus accumulated 2.360.1% of the total administered dose whereas
each right-sided fetus accumulated only 1.560.1% (p,10
-8 for left
versus right, n=76-79).
Figure 2. Final accumulation of glucose tracers. (a) Per gram accumulation of
18F in various tissues at 160 minutes after FDG infusion.
(* p,10
25 for left versus right, n=76–79). Per fetus (b) and per placenta (c) accumulation of
18F, based on uterine horn position. The fetus/placenta
closed to the cervix is counted as position 1. * p,0.05 left versus right. (d) Clearance of
3H into various tissues as measured after completion of the
scan (n.s. not significant for left versus right). Per fetus (e) and per placenta (f) accumulation of
3H, based on uterine horn position.
doi:10.1371/journal.pone.0012027.g002
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As a control for the unilaterally infused FDG, we centrally
administered [
3H]-2-deoxyglucose (2DG), a similar glucose
tracer, via subcutaneous injection just prior to initiation of the
PET scans. The resultant
3H serum activity exhibited a similar
profile to that of
18F (Fig. S1e,f). As with FDG, brain and heart
showed greater avidity for 2DG than did liver and skeletal muscle
(Fig. 2d). Fetuses and placentae also showed great avidity for
2DG. However, in contrast to
18F, the accumulation of
3H
was symmetric between the fetuses and placentae from the two
uterine horns (Fig. 2d). This was true across all uterine horn
positions (Fig. 2e,f).
Dynamic PET imaging
Dynamic PET images were acquired for the first 90 minutes
after initiating FDG infusion, with the field of view encompassing
the abdomen. By several minutes, the infusion catheter was clearly
visible (Fig. 3a). Early frames showed accumulation of FDG in
discoid structures superior to the catheter tip, the location and size
of the accumulation being consistent with the placentae of the left
Figure 3. Dynamic PET imaging. (a) Representative dynamic PET images, shown as maximum intensity projections. Dynamic scans were centered
on the abdomen. Minutes (‘‘m’’) after initiation of infusion are shown on each image. (b) SUV evolution for several anatomic structures. (c) SUV
evolution in the left and right uterine horns.
doi:10.1371/journal.pone.0012027.g003
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regions became progressively more uniformly populated with
radioactivity, representing movement of FDG into fetal tissues as
well. As expected, the kidneys became symmetrically visible and
then faded as FDG accumulated in the urinary bladder (Video S1).
These visualized phenomena were recapitulated in mean
standardized uptake values (SUVs) measured for these regions of
interest (Fig. 3b), reinforcing the qualitative impressions gleaned
from visualization of the dynamic images. The infusion catheter
SUV peaked early and intensely, fading significantly by 20
minutes. Renal SUV peaked at about 20 minutes, whereas right
uterus SUV reached a near plateau by 90 minutes, with far lower
SUV in skeletal muscle. Importantly, the left uterine horn
accumulated more FDG than the right uterine horn (Fig. 3c),
primarily due to enhanced FDG accumulation during the catheter
infusion phase, consistent with greater first pass exposure to
glucose tracer.
Whole-body PET imaging
A whole-body PET image was acquired at 90-120 minutes after
FDG infusion (Fig. 4a). High accumulations of FDG were evident
in glucose-avid tissues including the brain, harderian glands and
variably the heart and thoracic aspect of the catheter. As expected,
FDG concentrations were high within the bladder. The uterine
horns also were dominant structures of FDG accumulation, with
higher concentrations in the left uterine horn. There was good
correlation between SUVs determined either from the whole-body
scan for selected volumes of interest (VOIs) or from direct well-
counter-based assay of the
18F content of the corresponding tissues
collected after the scan (Fig. 4b), confirming the above qualitative
image-based impressions. Despite the overall excellent correlation
between in vivo imaging and ex vivo radioactivity concentration
determinations (Fig. 4b), minor discrepant trends were apparent.
In particular, PET-based SUV tended to underestimate uterine
and heart SUV. This likely is due to inactive uterine structures
(e.g. amniotic fluid) included in the image-based VOI analyses but
not in the radioactivity concentration determinations of extracted
tissue such as the placentae and fetuses which were blotted dry
prior to weighing and counting. The same may apply to the heart,
where the image-based VOI analyses would include the blood in
the ventricles that would not be included in the weights and well
counter-based assays. In contrast, PET-based SUV of brain
tended to be higher than well-counter SUV, perhaps due to bias in
drawing brain regions on ‘‘hotter’’ portions of the images.
Fetal response to catheter
Ligation of the uterine artery leads to intrauterine growth
retardation [27]. Gestational days 18-20 are a time of tremendous
growth; for example, one rat strain experiences a nearly tripling of
fetal weight during this interval [28]. It is thus conceivable that our
uterine artery catheter approach might impede blood flow to the
uterus thus impairing fetal growth. Arguing against this possibility,
there was no difference in fetal weight between the left and right
uterine horns at 3.5260.06 versus 3.5460.06 g (p=0.87, n=76-
79). There was a modest increase in placental size in the left
compared to right uterine horns at 0.5060.01 versus 0.4660.01 g
(p,0.005, n=76-79). Comparing by uterine position, no differ-
ences between left and right fetuses were apparent, whereas the
slightly increased placental size on the left was observed in several
positions (Fig. S2). Fetuses and placentae which developed further
from the cervix tended to be smaller than those more proximal to
the cervix, a trend which was observed both on the right and left
sides. No fetal deaths or resorptions were observed among these
scans and there was no difference in the number of fetuses between
Figure 4. PET whole-body imaging. (a) Representative maximum
intensity projection whole-body image. Color-intensity gradations are
indicated from least to greatest. (b) Correlation between standardized
uptake values (SUV) for volumes of interest as measured from the final
whole body image (SUVscan) and for the corresponding tissues as
determined by gamma well counter measurement, dose administered,
and weight of the rat and the tissue (SUVwell)( r=0.82, n=66, p,10
-16).
Abbreviations: RU – right uterine horn; LU – left uterine horn.
doi:10.1371/journal.pone.0012027.g004
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fetuses, p=ns, N=11).
Uterine artery catheter drainage
Some scans exhibited a lack of differential FDG accumulation
between the left and right uterine horn structures. We noted that
the scans lacking differential uptake typically also demonstrated a
predominance of early FDG distribution into non-uterine, caudal
structures such as the tail or left hindquarter (Fig. S3). We
reasoned that this was likely due to competing drainage of infusate
into other nearby arterial trunks arising from the iliac artery. By
dissection, we identified the hypogastric trunk and superior gluteal
arteries as potential diverting arterial drainages (Fig. 1b). We thus
tested the hypothesis that surgical approach ‘‘B’’, in which we
additionally tied off these two arterial trunks, would result in a
more differential FDG accumulation between the two uterine
horns. There was left-dominant FDG accumulation in both
surgical approaches, however surgical approach ‘‘B’’ as compared
to approach ‘‘A’’ resulted in greater left-sided selectivity calculated
either per mother (Fig. 5a) or per fetus (left/right=1.960.1 versus
1.360.1, n=27-30,38 for ‘‘B’’ and ‘‘A’’ respectively). By contrast,
the ratio of 2DG accumulation between the left and right horns
was essentially 1.0 in both surgical approaches.
We further tested the early FDG infusate drainage pattern for
association with the eventual left-versus-right uterine FDG
accumulation. We divided the scans into those that showed strong
or weak left-versus-right differential FDG accumulation on the 90
minute PET image. For each animal, we defined two volumes of
interest, one cranial and one caudal to the infusion catheter tip,
representing flow into the left uterine region or into caudal
structures of the rump, tail and hindquarter. The animals with
eventual strong left-versus-right differential accumulation exhibit-
ed increasing cranially-directed FDG peaking at 5 minutes,
indicative of immediate flow of the catheter infusate into the left
uterine structures (Fig. 5b). By contrast, among animals exhibiting
eventual weak left-versus-right differential accumulation, the
pattern was reversed, with a caudally-directed inverted peak at 5
minutes, indicative of direct infusate flow not towards the uterine
horn but rather into inferior structures. Thus, in a portion of our
scans, the infusate failed to experience first-pass exposure to the
left uterine horn; a situation improved by surgical approach ‘‘B’’.
Optimizing differential exposure
To explore the above considerations and optimize differential
exposure, we performed an additional series of PET scans in which
we infused 15 mm fluorescent microspheres (FMS) via the left
uterine artery catheter at the conclusion of the scan. The FMS are
unable to traverse the arterial to venous circulation, and thus are
used to quantitate blood flow to tissues including placenta [29]. As
expected, far greater FMS accumulated in placentae of the left
uterine horn than in structures not drained by the left uterine
artery including heart, liver and brain (Fig. 6a). However, the first
two right-sided fetuses also received a large portion of FMS on
average, though the terminal two right-sided fetuses did not.
Interestingly, the ratio of left-versus-right FMS was extremely
discrepant from scan to scan, with most scans showing a strong
left-sided selectivity but a few scans showed a right-sided selectivity
paradoxically (Fig. 6b). The change in selectivity was due primarily
to a reduction in left-sided (500680-fold, p,0.0005, n=8-19) and
less so to an increase in right-sided (863-fold, p,0.005, n=8-15)
FMS accumulation. The reasons for this alteration in flow pattern
were not readily discerned on dissection. When these right-sided-
FMS-flow scans were excluded, the remaining animals showed a
very high degree of left-sided flow selectivity (Fig. 6c). As
hypothesized, the right-sided-FMS-flow scans exhibited a caudal-
ly-directed pattern of FDG at 5 minutes as compared to the
strongly cranially-directed FDG appearance in the left-sided-FMS-
flow scans (Fig. 6d). Thus, a portion of catheterizations were
unsuccessful in directing infusate flow to the left uterus.
Importantly, across all scans, the chances of a selective infusion,
as defined as a fetal left-versus-right FDG selectivity ratio .1.6,
were far greater with surgical approach ‘‘B’’ (10 of 11) than ‘‘A’’ (2
of 6).
To further enhance the degree of left-versus-right uterine horn
FDG exposure, these scans (Fig. 6) were performed under
hyperinsulinemic conditions during euglycemic clamp. We
reasoned that, since insulin action shortens the plasma half-life
of circulating glucose, this would reduce the relative amount of left
uterine artery infused FDG reaching the right uterine horn.
Indeed, uterine horn SUVs were much stronger on the left than on
the right among the animals with left-sided-FMS-flow (Fig. 6e), a
pattern not seen in right-sided-FMS-flow animals despite hyper-
insulinemia (Fig. 6f). Furthermore, the right-sided-FMS-flow
animals showed a lack of differential FDG accumulation between
Figure 5. Impact of early FDG pattern on differential glucose exposure. (a) Impact of surgical approach on differential
18F (black bars) but
not
3H (white bars) accumulation (* p,0.05 for difference between approaches, n=5–6). (b) The ratio of
18F cranial versus caudal to the catheter tip is
plotted over time for scans that exhibited a final left/right uterine horn
18F ratio of .1.6 (SEL) or ,1.6 (NON). (*p,0.01, #p,0.001, n=5–6).
doi:10.1371/journal.pone.0012027.g005
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selecting left-sided-FMS-flow animals only under hyperinsulinemic
conditions, there was a 3.7-fold increased accumulation of FDG in
the left- versus right- uterine horn fetuses (p,10
-4, n=19-25)
(Fig. 6g, left-flow group; this data is shown by uterine horn position
in Fig. S4).
Chronic glucose infusions. We assessed the ability of this
approach to maintain differential glucose exposure between the
left uterine artery and systemic maternal circulation. A double
lumen catheter was placed on gestational day #18 using surgical
approach ‘‘B’’. Glucose was infused for 48 hours via the upstream
port at 4 mg/min and blood sampled via the downstream port.
This produced sustained and severe localized hyperglycemia at the
left uterine artery takeoff, while normal glycemia was maintained
in the maternal systemic circulation (Fig. 7).
Discussion
Here, we quantify an approach to expose the fetus in vivo to
isolated hyperglycemia by infusion of glucose into one of the
unilateral uterine arteries. As hypothesized, the ipsilateral fetuses
were exposed to significantly more hyperglycemia than contralat-
eral fetuses, with substantive first pass clearance of glucose into the
ipsilateral placentae and fetuses.
To best take advantage of this approach, ideally all of the
catheter infusate would be directed into uterine artery flow.
Although this could be achieved by direct catheterization of the
distal uterine artery, this would likely impede uterine blood flow.
We used a surgically simpler approach, similar to that reported in
studies of maternal-fetal metabolite [30] and toxin [31] transfer,
placing the catheter tip in the iliac artery near the uterine artery
takeoff [30]. Because several nearby arteries can divert a portion of
the infusate to structures other than the uterus, there are
competing interests between ligating arteries that divert flow and
minimizing surgical dissection. In our study, ligating two nearby
arteries improved uterine horn selectivity with a minimum of
additional dissection. Although additional ties could be placed, we
believe our approach ‘‘B’’ represents a reasonable balance
Figure 7. Chronic glucose infusion. Glucose was infused on
gestational days #18-20 at 4 mg/min via the left artery catheter.
Serum was sampled downstream of the infusion catheter tip (LU, black
squares) and from the maternal tail tip (mat, open circles). *p,0.05.
doi:10.1371/journal.pone.0012027.g007
Figure 6. Impact of infusate flow on differential glucose exposure. (a) Accumulation of fluorescent microspheres (FMS) in placenta by
laterality and position (1 is closest to cervix; z is closest to ovary) and tissues (L, liver; H, heart; B, brain). The number of FMS normalized to weight and
total number, such that a tissue receiving an average number per gram would have a relative drainage of 1. (b) Relative accumulation of FMS
between left and right, dividing the average number per left placenta by the average number per right placenta, among six individual scans. (c)
Accumulation of FMS in placenta and tissues only among scans showing left-dominant FMS accumulation. (d) The ratio of FDG concentration cranial
versus caudal to the catheter tip for scans that exhibited a left- or right-dominant FMS pattern (*p,0.05, n=2–4). (e-f) SUV in left uterine (LU) versus
right uterine (RU) horns for (e) left-dominant or (f) right-dominant FMS patterns. (g) Final accumulation of FDG in left and right fetuses and placenta
in scans showing left- or right- dominant FMS accumulation. (*p,10
-4, for left versus right
18F, n=19–25; ns p=not significant, n=8–20).
doi:10.1371/journal.pone.0012027.g006
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catheter flow to the left uterine horn was unexpectedly negligible
as assessed by early images from PET scanning, corroborated by
fluorescent microspheres (FMS). Importantly, this result illustrates
that FMS can be used as a means to assess catheter drainage
without the need for PET. FMS could be used to select those
animals which exhibit the desired flow pattern, thus removing
from consideration infusions that otherwise would dilute the effect
under study. On the other hand, strictly standardizing by FMS
flow could reduce the within-experiment variation in unintended
ways, reducing the degree to which results could be generalized
[32]. It is important to note that selection by flow pattern was not
required to obtain statistically significant degrees of differential
uterine horn exposure even when averaging across a small number
of animals.
The approach of directly providing excess macronutrients in vivo
to fetuses in one horn of the uterus has several advantages over
systemic induction of hyperglycemia [33] or diabetes. Importantly,
the induced hyperglycemia is localized. For example, infusion of 9
and 15 mg/min glucose induces mild and marked systemic
hyperglycemia in pregnant rats [34], whereas we find that infusion
of 4 mg/min glucose into the uterine artery at term raises the local
glucose concentration markedly but has little effect on maternal
systemic glucose levels. Another advantage is that the contralateral
fetuses serve as an ideal internal control. Fetuses from both sides
are exposed to essentially the same maternal milieu, with the
exception that the left-sided fetuses are additionally exposed to the
localized hyperglycemia. This approach can be thought of as an in
vivo compliment to in vitro embryo culture, which has been very
helpful in determining the effects of metabolic fuel excesses on fetal
development but does not perfectly recapitulate the in vivo situation
[33], [35], [36]. In fact, the idea of providing excess macronu-
trients in vivo to fetuses in one horn of the uterus is not new, having
been explored via transamniotic feeding [37] for example. One
additional advantage of directly infusing glucose into one uterine
artery is that the timing of hyperglycemia exposure can be finely
controlled temporally. For example, the fetal effects of brief
repeated episodes of hyperglycemia, such as occur during
pregnancy complicated by glucose variability in unstable type 1
diabetes, could be tested.
This approach has several limitations. As implied above, this
approach does not recapitulate the full effects of diabetes during
pregnancy, but rather is limited to the effects of hyperglycemia
local to the fetus. However, this limitation is of value to help
identify the individual metabolic fuels that contribute to fetal risk.
It is important to know which maternal metabolic fuels elevated in
diabetes to target in order to reduce fetal pathology [38], especially
given that maternal-sided interventions might have advantages
over fetal-sided interventions [39]. Additionally, the present work
was limited to late gestation, during which diabetes adversely
affects fetal growth, neonatal health [2], and programming of
adult disease [12], [13] but does not cause teratogenesis [7]. To
adapt this technique to the study of diabetes-related birth defects,
the catheter would need to be placed earlier in gestation to allow
hyperglycemic infusion during fetal organogenesis.
Our immediate plans with this model are to study the effects of
localized hyperglycemia on placental blood flow, fetal growth, and
islet development late in gestation. We also note that this approach
could be applied to other agents beyond glucose. A general
requirement for utility in this approach is that the agent tested
needs to be cleared rapidly from the circulation, otherwise
significant amounts will reach the contralateral horn. The half-
life of glucose in the circulation of the rat is on the order of 10-40
minutes [25]. This technique may be well suited to study other
rapidly cleared diabetes-related metabolites such as fatty acids
[40], triglycerides [41], and ketones [42]. Thus, this model is
ideally suited to test components of the Freinkel hypothesis in vivo.
Additionally, this method is likely applicable to other categories of
agents that affect mother and fetus, such as various toxins,
pharmaceuticals, and reactive oxygen species. We conclude that
this model approach creates isolated hyperglycemic fetal exposure
while maintaining relatively unexposed control fetuses in the
opposing uterine horn and that this approach is likely well-suited
to study of other agents that may impact on fetal health.
Materials and Methods
Animals
All procedures were performed within the regulations of the
Animal Welfare Act and the National Institutes of Health Guide
for the Care and Use of Laboratory Animals, and were approved
by the Institutional Animal Care and Use Committee of the
University of Iowa. Timed, pregnant Hsd:Sprague Dawley SD rats
(Harlan Laboratories, Inc.) were allowed one week to acclimate.
Gestational day 0 was defined as the day of initial vaginal plug
detection.
Uterine artery catheter
On gestational day 18, a vascular catheter draining into the left-
sided uterine artery was placed as follows. Anesthesia was induced
and maintained with inhalational isoflurane mixed with oxygen.
The femoral triangle was opened, and a stretched, sterilized PE10
catheter (Instech Laboratories Inc., Plymouth Meeting, PA) was
inserted and secured 1.65 cm retrograde into the femoral artery,
thus placing the tip several mm superior to the uterine artery
takeoff from the common iliac. The left inferior peritoneal space
was then opened and a silk ligature tied around the iliac artery
inferior to the uterine artery takeoff, typically just inferior to the
hypogastric trunk artery. In selected surgeries, the superior gluteal
and hypogastric trunk arteries were identified [43] and tied with
silk ligature at their origin. A right sided femoral artery catheter
was likewise placed except without intraperitoneal procedure.
Catheters were tunneled subcutaneously to a mid-scapular exit
and connected to a dual channel infusion swivel (Instech) allowing
the rat freedom of movement. Postoperative analgesia included
bupivacaine and buprenorphine. Saline with 5 U/mL heparin was
infused at 10 ml/min to maintain each catheter’s patency.
PET imaging
On gestational day 20, rats were anesthetized with 1.5%
isoflurane after overnight fast (13.660.9 h). Each animal was
maintained on a heated bed in dorsal recumbency, blood glucose
measured, a bladder catheter and rectal temperature probe
placed, and positioned in a MOSAIC microPET scanner (Philips
Medical Systems, Milpitas, CA, USA) with the abdomen
completely within the field of view as confirmed by transmission
scan using
137Cs. FDG was delivered in its standard buffer,
containing a trivial amount of glucose (,,6 mg/dL, formed as
by-product of the FDG synthesis), used for human clinical
infusions. At time zero, a dose of 3362 MBq
18FDG in
approximately 175 mL was infused at 20 mL/min via the uterine
artery catheter. Dynamic PET imaging (120 transaxial slices,
1 mm slice thickness) and blood sampling commenced at the start
of the FDG infusion (t=0). At 90-120 minutes, a whole-body
image of the rat from lower extremities to head was acquired (230
transaxial slices, 1 mm slice thickness) by movement of the scanner
bed through the gantry. The rat and its fetuses were then
euthanized with 150 mg/kg intravenous pentobarbital and the
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positioning of the left and right-sided fetuses was photodocumen-
ted prior to removal. Plasma samples and excised tissues were
weighed and the
18F content determined by assay in a previously
calibrated gamma NaI well-counter with decay correction to the
start of the radiotracer infusion.
Quantitative image analysis
Transaxial slices were reconstructed using a 3D Row Action
Maximum Likelihood Algorithm (Philips Medical Systems) on
projection data corrected for random coincidences, scatter, and
dead time. All images were attenuation- and decay- corrected.
PET images were scaled in standardized uptake values (SUV) by
normalizing to the administered FDG dose and the weight of the
animal. Image analysis was performed using PMOD 3.0 (PMOD
Technologies Ltd., Zurich, Switzerland). VOIs were defined
manually on transverse sections while viewing SUV data displayed
in four dimensions (transverse, sagittal, and coronal planes and
time). The anatomic regions representing the left and right uterine
horns were defined while comparing PET images to the respective
photodocuments.
Central 2-deoxyglucose tracing
In selected animals, 80 mCi of 2-[1,2-
3H(N)]-deoxy-D-glucose
(2DG) (New England Nuclear, PerkinElmer, Waltham, MA) was
injected subcutaneously in the axilla immediately before initiating
18FDG infusion. Tritium content was determined in tissue and
plasma samples after
18F decay. Tissues were dissolved in 4N
KOH overnight, the supernatant neutralized, and
3H content
determined by liquid scintillation counting. Glucose concentra-
tions were measured on whole-blood or plasma with a One Touch
Ultra meter (LifeScan Inc., Milpitas, CA).
Fluorescent microspheres
At the conclusion of selected PET scans, 1610
5 fluorescent
microspheres (FMS) (polystyrene, 15 mm, # F-8844, Invitrogen
Corp., Carlsbad, CA) were infused at 20 mL/min via the uterine
artery catheter. After
18F decay, the FMS content of selected
tissues was determined as follows. Each tissue was dissolved in
2.5 mL/g-tissue 4N KOH:2% Tween 80 overnight, then FMS
collected by filtration through a 5 mm pore size polycarbonate
membrane. After rinsing with 2% Tween 80, FMS were dissolved
from the membrane in 1 ml 2-ethoxyethyl acetate. Fluorescence
was quantitated in polypropylene multiwell plates using excitatio-
n:emission frequencies of 492:520 nm and compared to a
standardized curve.
Euglycemic hyperinsulinemic clamp during PET
After induction of anesthesia, insulin was infused via the right
femoral vein at 20 mU/kg/min. Glucose was infused via the same
catheter to maintain blood glucose at 90 mg/dL. FDG infusion
and PET imaging were initiated upon achievement of steady state
glucose infusion, at 9863 min after the initiation of insulin
infusion. The clamp was maintained during the PET imaging,
with the glucose infusion rate averaging 2660.4 mg/kg/min and
the blood glucose averaging 9061.7 mg/dL.
Glucose infusions with sampling
Glucose was infused via a double-lumen left-sided uterine artery
catheter for 48 hours on gestational days 18-20. The double-lumen
consisted of two adjacent heat-stretched, heat-melded PE10
catheters. Dextrose in 0.9% saline with 5 U/mL heparin was
infused via the upstream catheter tip at a rate of 4 mg/min and
20 ml/min. The second lumen tip, downstream by 2.5 mm, was
used for blood sampling and kept patent by 0.9% saline with
5 units/mL heparin infused at 10 mL/min. Simultaneous mater-
nal blood was obtained by tail-nick.
Statistical analyses
Error bars represent standard error of the means. Comparisons
between two independent samples were performed using two-
tailed homoscedastic Student’s t-tests. Paired samples were
compared using two-tailed repeated measures t-tests.
Supporting Information
Figure S1 Plasma sampling during PET. (a) Average serum
18F
concentration as sampled from the tail or right femoral artery,
showing correlation (b) from samples collected from both sites
simultaneously (r=0.80, p,10
-23, N=104). (c) Serum glucose as
measured from the tail or right femoral artery, showing correlation
(d) from samples collected from both sites simultaneously (r=0.83,
p,10
-24, N=92). (e) Average serum
3H concentration as sampled
from the tail or right femoral artery, showing correlation (f) from
samples collected from both sites simultaneously (r=0.87, p,10
-28,
N=95).
Found at: doi:10.1371/journal.pone.0012027.s001 (0.44 MB TIF)
Figure S2 Fetal and placental weights by uterine horn position.
Fetal (a) and placental (b) weights are shown by uterine horn
position. Position 1 is closest to the uterine cervix, with further
positions closer to the ovarian end of the uterine horn.
Found at: doi:10.1371/journal.pone.0012027.s002 (0.13 MB TIF)
Figure S3 Impact of early FDG pattern on differential glucose
exposure. Dynamic imaging, displayed as maximum intensity
projections, shows early FDG disposition caudal relative to the
catheter tip, in a scan that ultimately did not exhibit differential
glucose accumulation between uterine horns. Minutes (‘‘m’’) after
initiation of infusion are listed on each image.
Found at: doi:10.1371/journal.pone.0012027.s003 (1.45 MB TIF)
Figure S4 Fetal and placental
18F by uterine horn position.
Position 1 is closest to the uterine cervix, with further positions
closer to the ovarian end of the uterine horn. Per fetus (a) and per
placenta (b) accumulation of
18F. *p,0.05 for left versus right.
Found at: doi:10.1371/journal.pone.0012027.s004 (0.07 MB TIF)
Video S1 Video of representative dynamic PET. Serial dynamic
images collected during time 0-90 minutes, shown as maximum
intensity projections.
Found at: doi:10.1371/journal.pone.0012027.s005 (1.33 MB GIF)
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